Clinical Trial Update: A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update shows AP601 being studied in locally unresectable advanced or metastatic solid tumors, with recruitment ongoing. The sponsor is AP Bioscien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AP601

Snippet

Sponsor: AP Biosciences Inc. | Conditions: Solid Tumours | Phase 1 | Status: RECRUITING